Latest bladder cancer Stories
The Firm is filing Actos lawsuits on behalf of individuals who took Actos for an extended period of time and allegedly developed bladder cancer due to their use of the Type 2 diabetes medication.
Takeda Pharmaceuticals and marketing partner Eli Lilly & Co.
Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks.
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented this weekend at the American Association for Cancer Research Annual Conference 2014) details the discovery of a new genetic driver of bladder cancer: silencing of the gene AGL.
New Pre-Clinical Data Presented at AACR Annual Meeting in San Diego SAN DIEGO, April 7, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Researchers in Italy say their review of studies on the link between selenium and malignancies like bladder cancer turned up too little evidence to support supplementation. Raleigh,
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented this weekend at the American Association for Cancer
A new lawsuit filed on March 17, by a woman in Missouri Eastern District Court alleges that her father died from bladder cancer as a result of ingesting Actos.
A new UK report on the early warning signs of bladder cancer is especially relevant for diabetics and those who have taken Actos. Raleigh, NC (PRWEB) April 02,
Bladder cancer patients with metabolic syndrome – a set of conditions closely related to diabetes risk – are more likely to have a more invasive and fast-growing form of the disease.
- The word or words serving to define another word or expression, as in a dictionary entry.